Prophylactic OKT3: practical considerations for the prevention of first-dose reactions

Transplant Proc. 1993 Apr;25(2 Suppl 1):45-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azathioprine / therapeutic use*
  • Humans
  • Intraoperative Period
  • Kidney Transplantation / immunology*
  • Methylprednisolone / therapeutic use
  • Muromonab-CD3 / adverse effects
  • Muromonab-CD3 / therapeutic use*
  • Postoperative Period
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Muromonab-CD3
  • Tumor Necrosis Factor-alpha
  • Azathioprine
  • Methylprednisolone